Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Handa, Hiroshi
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
T
Handa H
,
Ishida T
,
Ozaki S
,
Mori A
,
Kato K
,
Iida S
.
Treatment pattern and clinical outcomes in multiple myeloma patients in Japan using the Medical Data Vision claims database.
PLoS One. 2023;18(4):e0283931.
PubMed
Google Scholar
R
Fuchida S-I
,
Ogura M
,
Ishida T
,
Hata H
,
Handa H
,
Katoh N
,
Nakaseko C
,
Sunami K
,
Katayama Y
,
Nobata H
, et al.
A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research Committee.
Int J Hematol. 2023.
PubMed
Google Scholar
O
Nakagawa N
,
Ishiyama K
,
Usuki K
,
Takada S
,
Tomikawa T
,
Handa H
,
Katsuoka Y
,
Hirano D
,
Sezaki N
,
Sumi M
, et al.
Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT.
Ann Hematol. 2023.
PubMed
Google Scholar
G
Kanamori T
,
Sanada M
,
Ri M
,
Ueno H
,
Nishijima D
,
Yasuda T
,
Tachita T
,
Narita T
,
Kusumoto S
,
Inagaki A
, et al.
Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort.
Br J Haematol. 2020.
PubMed
Google Scholar
E
Ozaki S
,
Handa H
,
Saitoh T
,
Murakami H
,
Itagaki M
,
Asaoku H
,
Suzuki K
,
Isoda A
,
Matsumoto M
,
Sawamura M
, et al.
Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma.
Ann Hematol. 2019.
PubMed
Google Scholar
A
Mori Y
,
Takizawa J
,
Katsuoka Y
,
Takezako N
,
Nagafuji K
,
Handa H
,
Kuroda J
,
Sunami K
,
Kamimura T
,
Ogawa R
, et al.
Autologous HSCT with novel agent-based induction and consolidation followed by lenalidomide maintenance for untreated multiple myeloma.
Cancer Sci. 2024.
PubMed
Google Scholar